{"time":37914,"apiVersion":"v1","queryOptions":{"metadata":true,"limit":-1,"skip":-1,"count":false},"response":[{"time":0,"dbTime":1,"numResults":1,"numTotalResults":1,"resultType":"uk.ac.ebi.eva.lib.models.VariantStudy","result":[{"name":"Prognostic factors of stable remission after cessation of TKI therapy in chronic myeloid leukemia by whole exome sequencing","id":"PRJEB9858","description":"Chronic myeloid leukemia can be well controlled by targeted tyrosine kinase inhibitors (TKI). In some patients it is possible to terminate expensive and toxic long-life therapy, however about 50% of these patients relapse without treatment. In our study we found promissing new potential early prognostic markers and molecular targets for developing new drugs.","taxonomyId":[9606],"speciesCommonName":"Human","speciesScientificName":"Homo sapiens","sourceType":"Germline","center":"Federal State Budgetary Institution «Research Centre For Medical Genetics», Moscow, Russia","material":"DNA","scope":"multi-isolate","experimentType":"Exome Sequencing","experimentTypeAbbreviation":"ES","assembly":"GRCh37","assemblyAccession":"GCA_000001405.1","platform":"Illumina","url":"http://www.med-gen.ru/en/","publications":["PubMed:26759060"],"numVariants":0,"numSamples":6,"browsable":false}]}]}